Combined tocainide and quinidine therapy for patients with coronary artery disease

Soo G. Kim, A. D. Mercando, John Devens Fisher

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Twenty patients who had coronary artery disease with frequent ventricular premature complexes were given tocainide and quinidine alone and in combination to evaluate the effectiveness of these three treatment modes in reducing ventricular premature complexes. The two drugs, when combined in less than maximal, well-tolerated doses, did not cause dose-related side effects and were more effective than maximal doses of either drug used alone.

Original languageEnglish (US)
Title of host publicationCardiology Board Review
Pages39-44
Number of pages6
Volume5
Edition2
StatePublished - 1988

Fingerprint

Tocainide
Quinidine
Ventricular Premature Complexes
Coronary Artery Disease
Maximum Tolerated Dose
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Kim, S. G., Mercando, A. D., & Fisher, J. D. (1988). Combined tocainide and quinidine therapy for patients with coronary artery disease. In Cardiology Board Review (2 ed., Vol. 5, pp. 39-44)

Combined tocainide and quinidine therapy for patients with coronary artery disease. / Kim, Soo G.; Mercando, A. D.; Fisher, John Devens.

Cardiology Board Review. Vol. 5 2. ed. 1988. p. 39-44.

Research output: Chapter in Book/Report/Conference proceedingChapter

Kim, SG, Mercando, AD & Fisher, JD 1988, Combined tocainide and quinidine therapy for patients with coronary artery disease. in Cardiology Board Review. 2 edn, vol. 5, pp. 39-44.
Kim SG, Mercando AD, Fisher JD. Combined tocainide and quinidine therapy for patients with coronary artery disease. In Cardiology Board Review. 2 ed. Vol. 5. 1988. p. 39-44
Kim, Soo G. ; Mercando, A. D. ; Fisher, John Devens. / Combined tocainide and quinidine therapy for patients with coronary artery disease. Cardiology Board Review. Vol. 5 2. ed. 1988. pp. 39-44
@inbook{3a4d8f5538c54e6a85293571f77a14fb,
title = "Combined tocainide and quinidine therapy for patients with coronary artery disease",
abstract = "Twenty patients who had coronary artery disease with frequent ventricular premature complexes were given tocainide and quinidine alone and in combination to evaluate the effectiveness of these three treatment modes in reducing ventricular premature complexes. The two drugs, when combined in less than maximal, well-tolerated doses, did not cause dose-related side effects and were more effective than maximal doses of either drug used alone.",
author = "Kim, {Soo G.} and Mercando, {A. D.} and Fisher, {John Devens}",
year = "1988",
language = "English (US)",
volume = "5",
pages = "39--44",
booktitle = "Cardiology Board Review",
edition = "2",

}

TY - CHAP

T1 - Combined tocainide and quinidine therapy for patients with coronary artery disease

AU - Kim, Soo G.

AU - Mercando, A. D.

AU - Fisher, John Devens

PY - 1988

Y1 - 1988

N2 - Twenty patients who had coronary artery disease with frequent ventricular premature complexes were given tocainide and quinidine alone and in combination to evaluate the effectiveness of these three treatment modes in reducing ventricular premature complexes. The two drugs, when combined in less than maximal, well-tolerated doses, did not cause dose-related side effects and were more effective than maximal doses of either drug used alone.

AB - Twenty patients who had coronary artery disease with frequent ventricular premature complexes were given tocainide and quinidine alone and in combination to evaluate the effectiveness of these three treatment modes in reducing ventricular premature complexes. The two drugs, when combined in less than maximal, well-tolerated doses, did not cause dose-related side effects and were more effective than maximal doses of either drug used alone.

UR - http://www.scopus.com/inward/record.url?scp=0023868686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023868686&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:0023868686

VL - 5

SP - 39

EP - 44

BT - Cardiology Board Review

ER -